The orphan nuclear receptor SHP is a positive regulator of osteoblastic bone formation

Journal of Bone and Mineral Research

Volumn 25, Issue 2, 2010, Pages 262-274

  Jeong, Byung Chul ^a   Lee, Yong Soo ^a   Bae, In Ho ^a   Lee, Chul Ho ^b   Shin, Hong In ^c   Ha, Hyun Jung ^d   Franceschi, Renny T ^e   Choi, Hueng Sik ^a   Koh, Jeong Tae ^a  

^a Chonnam National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Kyungpook National University   (South Korea)

^d Chungbuk National University   (South Korea)

^e UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

Bone Morphogenetic Protein (BMP); Orphan nuclear receptor; Osteoblast differentiation; Runx2; Small Heterodimer Partner (SHP)

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; HISTONE DEACETYLASE 4; ORPHAN NUCLEAR RECEPTOR; OSTEOCALCIN; SMALL HETERODIMER PARTNER; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; BMP2 PROTEIN, MOUSE; CELL RECEPTOR; HDAC5 PROTEIN, MOUSE; HISTONE DEACETYLASE; NUCLEAR RECEPTOR SUBFAMILY 0, GROUP B, MEMBER 2; RUNX2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; ANIMAL; BONE DEVELOPMENT; C57BL MOUSE; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOGENESIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 77953464424     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090718     Document Type: Article

References (48)

1. Seol W, Choi HS, Moore DD. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science. 1996;272:1336-1339. (Pubitemid 26199974)
2. Lee YS, Chanda D, Sim J, Park YY, Choi HS. Structure and function of the atypical orphan nuclear receptor small heterodimer partner. Int Rev Cytol. 2007;261:117-158. (Pubitemid 46856618)
3. Chanda D, Park JH, Choi HS. Molecular basis of endocrine regulation by orphan nuclear receptor small heterodimer partner. Endocr J. 2008;55:253-268. (Pubitemid 351670949)
4. Kim YD, Park KG, Lee YS, et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes. 2008;57:306-314.
5. Huang J, Iqbal J, Saha PK, et al. Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology. 2007;46:147-157. (Pubitemid 47171931)
6. Park KG, Lee KM, Seo HY, et al. Glucotoxicity in the INS-1 rat insulinoma cell line is mediated by the orphan nuclear receptor small heterodimer partner. Diabetes. 2007;56:431-437. (Pubitemid 46263068)
7. Song KH, Ellis E, Strom S, Chiang JY. Hepatocyte growth factor signaling pathway inhibits cholesterol 7α-hydroxylase and bile acid synthesis in human hepatocytes. Hepatology. 2007;46:1993-2002.
8. Olsen BR, Reginato AM, Wang W. Bone development. Annu Rev Cell Dev Biol. 2000;16:191-220.
9. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147. (Pubitemid 29282067)
10. Yamaguchi A, Komori T, Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev. 2000;21:393-411. (Pubitemid 32275586)
11. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem. 2006;99:1233-1239.
12. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242:1528-1534. (Pubitemid 19023695)
13. Franceschi RT, Ge C, Xiao G, Roca H, Jiang D. Transcriptional regulation of osteoblasts. Ann NY Acad Sci. 2007;1116:196-207.
14. Komori T. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem. 2005;95:445-453. (Pubitemid 41420175)
15. Banerjee C, McCabe LR, Choi JY, et al. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem. 1997;66:1-8. (Pubitemid 27284091)
16. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747-754. (Pubitemid 27516177)
17. Harada H, Tagashira S, Fujiwara M, et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem. 1999;274:6972-6978. (Pubitemid 129504980)
18. Lee KS, Kim HJ, Li QL, et al. Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol. 2000;20:8783-8792.
19. Sierra J, Villagra A, Paredes R, et al. Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol. 2003;23:3339-3351.
20. McLarren KW, Lo R, Grbavec D, Thirunavukkarasu K, Karsenty G, Stifani S. The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the runt-related factor Cbfa1. J Biol Chem. 2000;275:530-538. (Pubitemid 30039015)
21. Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional coactivator. EMBO J. 1999;18:2551-2562. (Pubitemid 29213286)
22. Westendorf JJ. Transcriptional co-repressors of Runx2. J Cell Biochem. 2006;98:54-64.
23. Takai H, Nakayama Y, Kim DS, et al. Androgen receptor stimulates bone sialoprotein (BSP) gene transcription via cAMP response element and activator protein 1/glucocorticoid response elements. J Cell Biochem. 2007;102:240-251. (Pubitemid 47378925)
24. Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor α and induction of Fas ligand in osteoclasts. Cell. 2007;130:811-823. (Pubitemid 47332572)
25. Zirngibl RA, Chan JS, Aubin JE. Estrogen receptor-related receptor α (ERRα) regulates osteopontin expression through a non-canonical ERRα response element in a cell context-dependent manner. J Mol Endocrinol. 2008;40:61-73.
26. Lee HK, Lee YK, Park SH, et al. Structure and expression of the orphan nuclear receptor SHP gene. J Biol Chem. 1998;273:14398-14402. (Pubitemid 28319159)
27. Kim JY, Kim HJ, Kim KT, et al. Orphan nuclear receptor small heterodimer partner represses hepatocyte nuclear factor 3/Foxa transactivation via inhibition of its DNA binding. Mol Endocrinol. 2004;18:2880-2894.
28. Lee YS, Kim DK, Kim YD, et al. Orphan nuclear receptor SHP interacts with and represses hepatocyte nuclear factor-6 (HNF-6) transactivation. Biochem J. 2008;413:559-569.
29. Phimphilai M, Zhao Z, Boules H, Roca H, Franceschi RT. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Miner Res. 2006;21:637-646.
30. Ichida F, Nishimura R, Hata K, et al. Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J Biol Chem. 2004;279:34015-34022. (Pubitemid 39063053)
31. Manolagas SC, Burton DW, Deftos LJ. 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem. 1981;256:7115-7117.
32. Kim H, Choi HK, Shin JH, et al. Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J Clin Invest. 2009;119:813-825.
33. Park YJ, Qatanani M, Chua SS, et al. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis. Hepatology. 2008;47:1578-1586. (Pubitemid 351702741)
34. Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol. 1993;12:871-880. (Pubitemid 24293712)
35. Chen Y, Bhushan A, Vale W. Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase. Proc Natl Acad Sci USA. 1997;94:12938-12943. (Pubitemid 27518455)
36. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun. 1991;174:96-101.
37. Puleo DA. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. J Cell Physiol. 1997;173:93-101.
38. Khosla S, Westendorf JJ, Oursler MJ. Building bone to reverse osteoporosis and repair fractures. J Clin Invest. 2008;118:421-428. (Pubitemid 351206529)
39. Makita N, Suzuki M, Asami S, et al. Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells. Gene. 2008;413:8-17.
40. Vega RB, Matsuda K, Oh J, et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell. 2004;119:555-566. (Pubitemid 39482354)
41. Tsuji K, Bandyopadhyay A, Harfe BD, et al. BMP-2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet. 2006;38:1424-1429. (Pubitemid 44837565)
42. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature. 2003;423:349-355. (Pubitemid 40852710)
43. Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003;4:638-649. (Pubitemid 36917505)
44. Kassam A, Capone JP, Rachubinski RA. The short heterodimer partner receptor differentially modulates peroxisome proliferator-activated receptor alpha-mediated transcription from the peroxisome proliferator-response elements of the genes encoding the peroxisomal beta-oxidation enzymes acyl-CoA oxidase and hydratase-dehydrogenase. Mol Cell Endocrinol. 2001;176:49-56. (Pubitemid 32454934)
45. Nishizawa H, Yamagata K, Shimomura I, et al. Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation. J Biol Chem. 2002;277:1586-1592. (Pubitemid 34968917)
46. Park MJ, Kim KH, Kim HY, Kim K, Cheong J. Bile acid induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human gastric cancer cells. Carcinogenesis. 2008;29:2385-2393.
47. Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R. Toward a molecular understanding of skeletal development. Cell. 1995;80: 371-378.
48. Farhana L, Dawson MI, Leid M, et al. Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor. Cancer Res. 2007;67:318-325. (Pubitemid 46142790)